These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12534074)

  • 1. [Systemic fungal infections in severely ill patients. When opportunistic pathogens decided between life or death].
    MMW Fortschr Med; 2002 Nov; 144(46):12. PubMed ID: 12534074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients].
    Pfaffenbach B; Donhuijsen K; Pahnke J; Bug R; Adamek RJ; Wegener M; Ricken D
    Med Klin (Munich); 1994 Jun; 89(6):299-304. PubMed ID: 8072452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B-related thrombocytopenia. A report of two cases.
    Charak BS; Iyer RS; Rajoor BG; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1990 Mar; 38(3):235-6. PubMed ID: 2391305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal management in cancer patients.
    Staber P; Langner S; Dornbusch HJ; Neumeister P
    Wien Med Wochenschr; 2007; 157(19-20):503-10. PubMed ID: 18030555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of intracavitary amphotericin B in the treatment of aspergilloma associated with the acquired immunodeficiency syndrome].
    Pintado V; Montilla P; Casado JL; Guerrero A
    Med Clin (Barc); 1994 Sep; 103(7):279. PubMed ID: 7934299
    [No Abstract]   [Full Text] [Related]  

  • 6. American Thoracic Society. Medical section of the American Lung Association. Treatment of fungal diseases.
    Am Rev Respir Dis; 1979 Dec; 120(6):1393-7. PubMed ID: 517865
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial. Fungal infections have emerged as major causes of morbidity and mortality in the last decade.
    Severo CB; Severo LC; Fischer GB
    Paediatr Respir Rev; 2009 Dec; 10(4):159-60. PubMed ID: 19879503
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
    Ho KM; Duff O; Chambers D; Murray R
    Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI; Chandrasekar PH; Hooshmand-Rad R
    Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of mycetomas and men.
    Lick S; Duarte A
    Chest; 2002 Jan; 121(1):5-6. PubMed ID: 11796422
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host.
    Lin CM; Tsai YH; Huang CC; Lee CH; Chiang PC; Huang SF; Liu HP
    J Infect; 2006 Aug; 53(2):e55-8. PubMed ID: 16325257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with econazole of a case of pulmonary aspergillosis.
    Hantschke D; Schulte R; Dabag S; Greschuna D
    Mykosen Suppl; 1978; 1():230-5. PubMed ID: 299479
    [No Abstract]   [Full Text] [Related]  

  • 15. A survey of anti-fungal management in lung transplantation.
    Dummer JS; Lazariashvilli N; Barnes J; Ninan M; Milstone AP
    J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
    Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
    J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Birefringent crystals in a lung cavity.
    Harigopal P; Bejarano P; Burke G; Dowdy LM
    Clin Infect Dis; 2005 Jun; 40(12):1806, 1849-50. PubMed ID: 15912600
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
    Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
    Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.